3.200USD+3.23%Mkt Cap: 365.29M $P/E: —1d ago
Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap365.29M $
Enterprise Value120.96M $
Revenue (TTM)409.00K $
Gross Profit-95.77M $
Net Income (TTM)-103.12M $
Revenue/Share0.0040 USD
Last Price3.200 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees163
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.86
PEG—
EV/EBITDA-1.00
EV/Revenue295.74
P/S893.12
P/B1.13
EPS (TTM)-1.33
EPS (Forward)-1.12
52W Range
1.96030% of range6.160
52W High6.160 USD
52W Low1.960 USD
Profitability
Gross Margin0.00%
Oper. Margin-36120.99%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-49.81%
ROA-38.63%
Growth
Revenue Growth-72.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-82.48M $
CapEx (TTM)12.75M $
FCF Margin-16974.48%
FCF Yield-19.01%
Net Debt-232.91M $
Net Debt/EBITDA1.92
Balance Sheet
Debt/Equity0.02
Current Ratio6.61
Quick Ratio6.49
Book Value/Sh2.839 USD
Cash/Share2.075 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 17, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.64 USD
Upside (mean)+295.1%
Target Range6.000 USD – 18.00 USD
$6.000+295.1% to mean$18.00
# Analysts14
Ownership
Shares Out.114.15M
Float68.41M
Insiders10.80%
Institutions86.82%
Short Interest
Short Ratio15.0d
Short % Float24.58%
Short % Out.20.57%
Shares Short23.47M
Short (prev mo.)22.72M
Technical
SMA 503.083 (+3.8%)
SMA 2003.505 (-8.7%)
Beta1.80
S&P 52W Chg20.92%
Avg Vol (30d)1.34M
Avg Vol (10d)1.25M
Technical Indicators
RSI (14)55.6
MACD0.0025
MACD Signal-0.0402
MACD Hist.+0.0427
BB Upper3.220 USD
BB Middle2.993 USD
BB Lower2.765 USD
BB Width15.21%
ATR (14)0.1843 USD
Vol Ratio (20d)0.99x